SPIA
VIR icon

Steward Partners Investment Advisory’s Vir Biotechnology VIR Stock Holding History

Steward Partners Investment Advisory’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-300
Closed -$1.71K – 4474
2025
Q3 		$1.71K Hold
300
– – ﹤0.01% 3960
2025
Q2 		$1.51K Hold
300
– – ﹤0.01% 3793
2025
Q1 		$1.94K Buy
+300
New +$2.67K ﹤0.01% 3651

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GP
GSK plc London $602M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Steward Partners Investment Advisory's VIR Position: Q4 2025 in Review

Steward Partners Investment Advisory sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 300 shares — an estimated $1.71K sold.

Steward Partners Investment Advisory first reported a position in VIR in Q1 2025 and held it in 3 quarters. The position peaked at $1.94K in Q1 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

  • Steward Partners Investment Advisory reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
  • Steward Partners Investment Advisory sold 300 Vir Biotechnology shares in Q4 2025, an estimated $1.71K.
  • Steward Partners Investment Advisory first reported a position in Vir Biotechnology in Q1 2025 and held it in 3 quarters.
  • Steward Partners Investment Advisory's Vir Biotechnology position peaked at $1.94K in Q1 2025.
  • 218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2025, filed 12 Feb 2026.